Publication | Closed Access

Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model

InflammationNanomedicineCell-based Drug DeliveryMedicineImmunologyGastroenterologyPolymeric NanocarriersCyclosporine ANano-drug DeliveryDrug Delivery SystemImmunotherapyPharmacologyRelevant Mouse Model